Synthesis  ||| S:0 E:10 ||| NNP
and  ||| S:10 E:14 ||| CC
molecular  ||| S:14 E:24 ||| JJ
modelling  ||| S:24 E:34 ||| JJ
studies  ||| S:34 E:42 ||| NNS
of  ||| S:42 E:45 ||| IN
8-arylpyrido ||| S:45 E:57 ||| NNP
[ ||| S:57 E:58 ||| -LRB-
3 ||| S:58 E:59 ||| NNP
' ||| S:59 E:60 ||| POS
, ||| S:60 E:61 ||| ,
2 ||| S:61 E:62 ||| CD
' ||| S:62 E:63 ||| ''
: ||| S:63 E:64 ||| :
4,5 ||| S:64 E:67 ||| CD
] ||| S:67 E:68 ||| -RRB-
thieno ||| S:68 E:74 ||| NNS
[ ||| S:74 E:75 ||| -LRB-
3,2-d ||| S:75 E:80 ||| NNP
] ||| S:80 E:81 ||| -RRB-
pyrimidin-4-amines  ||| S:81 E:100 ||| CD
as  ||| S:100 E:103 ||| IN
multitarget  ||| S:103 E:115 ||| FW
Ser ||| S:115 E:118 ||| FW
/ ||| S:118 E:119 ||| FW
Thr  ||| S:119 E:123 ||| FW
kinases  ||| S:123 E:131 ||| FW
inhibitors  ||| S:131 E:142 ||| FW
This  ||| S:142 E:147 ||| DT
paper  ||| S:147 E:153 ||| NN
reports  ||| S:153 E:161 ||| VBZ
the  ||| S:161 E:165 ||| DT
design  ||| S:165 E:172 ||| NN
and  ||| S:172 E:176 ||| CC
synthesis  ||| S:176 E:186 ||| NN
of  ||| S:186 E:189 ||| IN
a  ||| S:189 E:191 ||| DT
novel  ||| S:191 E:197 ||| NN
series  ||| S:197 E:204 ||| NN
of  ||| S:204 E:207 ||| IN
8-arylpyrido ||| S:207 E:219 ||| NNP
[ ||| S:219 E:220 ||| -LRB-
3 ||| S:220 E:221 ||| NNP
' ||| S:221 E:222 ||| POS
, ||| S:222 E:223 ||| ,
2 ||| S:223 E:224 ||| CD
' ||| S:224 E:225 ||| ''
: ||| S:225 E:226 ||| :
4,5 ||| S:226 E:229 ||| CD
] ||| S:229 E:230 ||| -RRB-
thieno ||| S:230 E:236 ||| NNS
[ ||| S:236 E:237 ||| -LRB-
3,2-d ||| S:237 E:242 ||| NNP
] ||| S:242 E:243 ||| -RRB-
pyrimidin-4-amines  ||| S:243 E:262 ||| CD
via  ||| S:262 E:266 ||| IN
microwave-assisted  ||| S:266 E:285 ||| JJ
multi-step  ||| S:285 E:296 ||| JJ
synthesis ||| S:296 E:305 ||| NN
.  ||| S:305 E:307 ||| .
A  ||| S:307 E:309 ||| DT
common  ||| S:309 E:316 ||| JJ
precursor  ||| S:316 E:326 ||| NN
of  ||| S:326 E:329 ||| IN
the  ||| S:329 E:333 ||| DT
whole  ||| S:333 E:339 ||| JJ
series ||| S:339 E:345 ||| NN
,  ||| S:345 E:347 ||| ,
3-amino-5-bromothieno ||| S:347 E:368 ||| NNP
[ ||| S:368 E:369 ||| -LRB-
2,3-b ||| S:369 E:374 ||| NNP
] ||| S:374 E:375 ||| -RRB-
pyridine-2-carbonitrile ||| S:375 E:398 ||| NNP
,  ||| S:398 E:400 ||| ,
was  ||| S:400 E:404 ||| VBD
rapidly  ||| S:404 E:412 ||| RB
synthesized  ||| S:412 E:424 ||| VBN
in  ||| S:424 E:427 ||| IN
one  ||| S:427 E:431 ||| CD
step  ||| S:431 E:436 ||| NN
from  ||| S:436 E:441 ||| IN
commercially-available  ||| S:441 E:464 ||| JJ
5-bromo-2-chloronicotinonitrile ||| S:464 E:495 ||| NN
.  ||| S:495 E:497 ||| .
Formylation  ||| S:497 E:509 ||| NNP
with  ||| S:509 E:514 ||| IN
DMF-DMA  ||| S:514 E:522 ||| NNP
led  ||| S:522 E:526 ||| VBD
to  ||| S:526 E:529 ||| TO
( ||| S:529 E:530 ||| -LRB-
E ||| S:530 E:531 ||| NNP
) ||| S:531 E:532 ||| -RRB-
-N ||| S:532 E:534 ||| JJ
' ||| S:534 E:535 ||| ''
- ||| S:535 E:536 ||| :
( ||| S:536 E:537 ||| -LRB-
5-bromo-2-cyanothieno ||| S:537 E:558 ||| NNP
[ ||| S:558 E:559 ||| -LRB-
2,3-b ||| S:559 E:564 ||| NNP
] ||| S:564 E:565 ||| -RRB-
pyridin-3-yl ||| S:565 E:577 ||| CD
) ||| S:577 E:578 ||| -RRB-
-N ||| S:578 E:580 ||| NNP
, ||| S:580 E:581 ||| ,
N-dimethylformimidamide  ||| S:581 E:605 ||| NNP
( ||| S:605 E:606 ||| -LRB-
4 ||| S:606 E:607 ||| LS
)  ||| S:607 E:609 ||| -RRB-
which  ||| S:609 E:615 ||| WDT
was  ||| S:615 E:619 ||| VBD
conveniently  ||| S:619 E:632 ||| RB
functionalized  ||| S:632 E:647 ||| VBN
at  ||| S:647 E:650 ||| IN
position  ||| S:650 E:659 ||| NN
8  ||| S:659 E:661 ||| CD
by  ||| S:661 E:664 ||| IN
palladium-catalyzed  ||| S:664 E:684 ||| JJ
Suzuki-Miyaura  ||| S:684 E:699 ||| JJ
cross-coupling  ||| S:699 E:714 ||| JJ
to  ||| S:714 E:717 ||| TO
introduce  ||| S:717 E:727 ||| VB
a  ||| S:727 E:729 ||| DT
heteroaromatic  ||| S:729 E:744 ||| JJ
ring ||| S:744 E:748 ||| NN
.  ||| S:748 E:750 ||| .
High-temperature  ||| S:750 E:767 ||| JJ
formamide-mediated  ||| S:767 E:786 ||| JJ
cyclization  ||| S:786 E:798 ||| NN
of  ||| S:798 E:801 ||| IN
the  ||| S:801 E:805 ||| DT
cyanoamidine  ||| S:805 E:818 ||| FW
intermediate  ||| S:818 E:831 ||| FW
gave  ||| S:831 E:836 ||| FW
seventeen  ||| S:836 E:846 ||| FW
8-arylpyrido ||| S:846 E:858 ||| FW
[ ||| S:858 E:859 ||| -LRB-
3 ||| S:859 E:860 ||| NNP
' ||| S:860 E:861 ||| POS
, ||| S:861 E:862 ||| ,
2 ||| S:862 E:863 ||| CD
' ||| S:863 E:864 ||| ''
: ||| S:864 E:865 ||| :
4,5 ||| S:865 E:868 ||| CD
] ||| S:868 E:869 ||| -RRB-
thieno ||| S:869 E:875 ||| NNS
[ ||| S:875 E:876 ||| -LRB-
3,2-d ||| S:876 E:881 ||| NNP
] ||| S:881 E:882 ||| -RRB-
pyrimidin-4-amines ||| S:882 E:900 ||| NNP
.  ||| S:900 E:902 ||| .
The  ||| S:902 E:906 ||| DT
inhibitory  ||| S:906 E:917 ||| JJ
potency  ||| S:917 E:925 ||| NN
of  ||| S:925 E:928 ||| IN
the  ||| S:928 E:932 ||| DT
final  ||| S:932 E:938 ||| JJ
products  ||| S:938 E:947 ||| NNS
was  ||| S:947 E:951 ||| VBD
evaluated  ||| S:951 E:961 ||| VBN
against  ||| S:961 E:969 ||| IN
five  ||| S:969 E:974 ||| CD
protein  ||| S:974 E:982 ||| NN
kinases  ||| S:982 E:990 ||| NNS
( ||| S:990 E:991 ||| -LRB-
CDK5 ||| S:991 E:995 ||| NNP
/ ||| S:995 E:996 ||| NNP
p25 ||| S:996 E:999 ||| NNP
,  ||| S:999 E:1001 ||| ,
CK1δ ||| S:1001 E:1005 ||| CD
/ ||| S:1005 E:1006 ||| CD
ε ||| S:1006 E:1007 ||| NN
,  ||| S:1007 E:1009 ||| ,
GSK3α ||| S:1009 E:1014 ||| CD
/ ||| S:1014 E:1015 ||| CD
β ||| S:1015 E:1016 ||| NN
,  ||| S:1016 E:1018 ||| ,
DYRK1A  ||| S:1018 E:1025 ||| NNP
and  ||| S:1025 E:1029 ||| CC
CLK1 ||| S:1029 E:1033 ||| CD
)  ||| S:1033 E:1035 ||| -RRB-
and  ||| S:1035 E:1039 ||| CC
revealed  ||| S:1039 E:1048 ||| VBD
that  ||| S:1048 E:1053 ||| IN
8- ||| S:1053 E:1055 ||| NNP
( ||| S:1055 E:1056 ||| -LRB-
2,4-dichlorophenyl ||| S:1056 E:1074 ||| NNP
) ||| S:1074 E:1075 ||| -RRB-
pyrido ||| S:1075 E:1081 ||| NNS
[ ||| S:1081 E:1082 ||| -LRB-
3 ||| S:1082 E:1083 ||| NNP
' ||| S:1083 E:1084 ||| POS
, ||| S:1084 E:1085 ||| ,
2 ||| S:1085 E:1086 ||| CD
' ||| S:1086 E:1087 ||| ''
: ||| S:1087 E:1088 ||| :
4,5 ||| S:1088 E:1091 ||| CD
] ||| S:1091 E:1092 ||| -RRB-
thieno ||| S:1092 E:1098 ||| NNS
[ ||| S:1098 E:1099 ||| -LRB-
3,2-d ||| S:1099 E:1104 ||| NNP
] ||| S:1104 E:1105 ||| -RRB-
pyrimidin-4-amine  ||| S:1105 E:1123 ||| FW
1g  ||| S:1123 E:1126 ||| FW
specifically  ||| S:1126 E:1139 ||| FW
inhibits  ||| S:1139 E:1148 ||| FW
CK1δ ||| S:1148 E:1152 ||| FW
/ ||| S:1152 E:1153 ||| FW
ε  ||| S:1153 E:1155 ||| FW
and  ||| S:1155 E:1159 ||| CC
CLK1  ||| S:1159 E:1164 ||| NNP
( ||| S:1164 E:1165 ||| -LRB-
220  ||| S:1165 E:1169 ||| CD
and  ||| S:1169 E:1173 ||| CC
88 nM ||| S:1173 E:1178 ||| NNP
,  ||| S:1178 E:1180 ||| ,
respectively ||| S:1180 E:1192 ||| RB
)  ||| S:1192 E:1194 ||| -RRB-
while  ||| S:1194 E:1200 ||| IN
its  ||| S:1200 E:1204 ||| PRP$
7- ||| S:1204 E:1206 ||| NNP
( ||| S:1206 E:1207 ||| -LRB-
2,4-dichlorophenyl ||| S:1207 E:1225 ||| NNP
) ||| S:1225 E:1226 ||| -RRB-
pyrido ||| S:1226 E:1232 ||| NNS
[ ||| S:1232 E:1233 ||| -LRB-
3 ||| S:1233 E:1234 ||| NNP
' ||| S:1234 E:1235 ||| POS
, ||| S:1235 E:1236 ||| ,
2 ||| S:1236 E:1237 ||| CD
' ||| S:1237 E:1238 ||| ''
: ||| S:1238 E:1239 ||| :
4,5 ||| S:1239 E:1242 ||| CD
] ||| S:1242 E:1243 ||| -RRB-
thieno ||| S:1243 E:1249 ||| NNS
[ ||| S:1249 E:1250 ||| -LRB-
3,2-d ||| S:1250 E:1255 ||| NNP
] ||| S:1255 E:1256 ||| -RRB-
pyrimidin-4-amine  ||| S:1256 E:1274 ||| CD
isomer  ||| S:1274 E:1281 ||| CD
10  ||| S:1281 E:1284 ||| CD
showed  ||| S:1284 E:1291 ||| VBD
no  ||| S:1291 E:1294 ||| DT
activity  ||| S:1294 E:1303 ||| NN
on  ||| S:1303 E:1306 ||| IN
the  ||| S:1306 E:1310 ||| DT
panel  ||| S:1310 E:1316 ||| NN
of  ||| S:1316 E:1319 ||| IN
tested  ||| S:1319 E:1326 ||| JJ
kinases ||| S:1326 E:1333 ||| NN
.  ||| S:1333 E:1335 ||| .
Molecular  ||| S:1335 E:1345 ||| JJ
modelling  ||| S:1345 E:1355 ||| NN
of  ||| S:1355 E:1358 ||| IN
10  ||| S:1358 E:1361 ||| CD
and  ||| S:1361 E:1365 ||| CC
1g  ||| S:1365 E:1368 ||| CD
in  ||| S:1368 E:1371 ||| IN
the  ||| S:1371 E:1375 ||| DT
ATP  ||| S:1375 E:1379 ||| NNP
binding  ||| S:1379 E:1387 ||| JJ
sites  ||| S:1387 E:1393 ||| NNS
of  ||| S:1393 E:1396 ||| IN
CK1δ ||| S:1396 E:1400 ||| CD
/ ||| S:1400 E:1401 ||| CD
ε  ||| S:1401 E:1403 ||| NNS
and  ||| S:1403 E:1407 ||| CC
CLK1  ||| S:1407 E:1412 ||| NNP
showed  ||| S:1412 E:1419 ||| VBD
that  ||| S:1419 E:1424 ||| DT
functionalization  ||| S:1424 E:1442 ||| NN
at  ||| S:1442 E:1445 ||| IN
position  ||| S:1445 E:1454 ||| NN
7  ||| S:1454 E:1456 ||| CD
of  ||| S:1456 E:1459 ||| IN
pyrido ||| S:1459 E:1465 ||| NNS
[ ||| S:1465 E:1466 ||| -LRB-
3 ||| S:1466 E:1467 ||| NNP
' ||| S:1467 E:1468 ||| POS
, ||| S:1468 E:1469 ||| ,
2 ||| S:1469 E:1470 ||| CD
' ||| S:1470 E:1471 ||| ''
: ||| S:1471 E:1472 ||| :
4,5 ||| S:1472 E:1475 ||| CD
] ||| S:1475 E:1476 ||| -RRB-
thieno ||| S:1476 E:1482 ||| NNS
[ ||| S:1482 E:1483 ||| -LRB-
3,2-d ||| S:1483 E:1488 ||| NNP
] ||| S:1488 E:1489 ||| -RRB-
pyrimidin-4-amines  ||| S:1489 E:1508 ||| NNP
is  ||| S:1508 E:1511 ||| VBZ
likely  ||| S:1511 E:1518 ||| JJ
to  ||| S:1518 E:1521 ||| TO
induce  ||| S:1521 E:1528 ||| VB
a  ||| S:1528 E:1530 ||| DT
steric  ||| S:1530 E:1537 ||| JJ
clash  ||| S:1537 E:1543 ||| NN
on  ||| S:1543 E:1546 ||| IN
the  ||| S:1546 E:1550 ||| DT
CK1δ ||| S:1550 E:1554 ||| CD
/ ||| S:1554 E:1555 ||| CD
ε  ||| S:1555 E:1557 ||| CD
P-loop  ||| S:1557 E:1564 ||| JJ
and  ||| S:1564 E:1568 ||| CC
thus  ||| S:1568 E:1573 ||| RB
a  ||| S:1573 E:1575 ||| DT
complete  ||| S:1575 E:1584 ||| JJ
loss  ||| S:1584 E:1589 ||| NN
of  ||| S:1589 E:1592 ||| IN
inhibitory  ||| S:1592 E:1603 ||| JJ
activity ||| S:1603 E:1611 ||| NN
.  ||| S:1611 E:1613 ||| .
